Following the enormous success of our Paediatric Drug Development and Clinical Trials event last year, VIBpharma is proud to announce the dates for our second annual Paediatric Drug Development and Clinical Trials conference this November.

Since the introduction and implementation of the paediatric regulation in 2006, both pharma companies and the regulators alike have faced many challenges. From clarification of the waiver and deferral processes to practical implementation of the legislation and best practice techniques when submitting a PIP, this event will shed light on key issues affecting you today.

VIBpharma’s Paediatric Drug Development and Clinical Trials conference will bring together major pharma and biotech manufacturers as well as the regulators to find solutions to this complex issue. This event will also cover topics such as the running of the studies themselves, including patient recruitment and retention, the informed consent/assent process, paediatric formulations, adverse event reporting and getting approval from Ethical Committees, by case study driven presentations from leading experts in this area.

This educational two-day conference, tailored to maximise the sharing of knowledge and expertise and to promote networking for professionals in this area, will ensure you meet the legislative requirements to increase the knowledge of medicines for children and facilitate medical advancements for the next generation.